The EU Joint Programme for Neurodegenerative Disease Research (JPND) has announced €35 million (£25.7 million) funding for research into neurodegenerative diseases. Nine of the 21 research projects involved will benefit UK research teams; these will receive MRC funds through the JPND initiative.
The collaborative funding scheme, known as JPcofuND, involves a transnational (quasi-global) approach to pooling funds from JPND member organisations with the European Commission. The 9 JPND projects to be funded through the JPcofuND scheme which involve UK teams are:
- ADAGE: Alzheimer’s Disease pathology within the ageing physiology.
- aSynProtec: Alpha-synuclein pathology propagation in Parkinson’s disease and quest for novel protective strategies.
- BRIDGET: Brain imaging, cognition, dementia and next generation GEnomics: a Transdisciplinary approach to search for risk and protective factors of neurodegenerative disease.
- EADB: A European DNA bank for deciphering the missing heritability of Alzheimer’s disease.
- EPI-AD: Targeting epigenetic dysregulation in the brainstem in Alzheimer’s Disease.
- ESMI: European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative.
- GBA-PARK: GBA1 mutations in Parkinson disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention.
- INSTALZ: Genomic Instability in Alzheimer’s Disease and Related Disorders: a Single-Cell Approach.
- EfrAME: Pathway complexities of protein misfolding in neurodegenerative diseases: a novel approach to risks evaluation and model development.
Multimillion euro boost to international dementia research. London: Medical Research Council (MRC), October 8th 2015.
A full list of the 21 project proposals recommended for funding is available:
[Untitled Document on the 21 Successful Research Projects]. [Online:] Joint Programme for Neurodegenerative Disease Research (JPND), October 8th 2015.